Uncommon Therapeutics

Uncommon Therapeutics is a biotechnology company focused on developing innovative treatments for rare and uncommon diseases. The company employs advanced technologies to create pharmaceuticals that specifically target the underlying causes of these conditions. Their initial focus is on Rett Syndrome, a neurodevelopmental monogenetic disease that affects approximately 1 in 10,000 girls. This highlights their commitment to addressing significant unmet medical needs in the field of rare diseases.

The approach taken by Uncommon Therapeutics is characterized by deep domain knowledge and a team of…